Literature DB >> 9003340

Subfoveal choroidal neovascularization in punctate inner choroidopathy. Surgical management and pathologic findings.

T W Olsen1, A Capone, P Sternberg, H E Grossniklaus, D F Martin, T M Aaberg.   

Abstract

PURPOSES: To evaluate submacular surgery for the management of subfoveal choroidal neovascularization in punctate inner choroidopathy, to describe the histopathology and ultrastructure of the excised subretinal tissue, and to propose a staging system that characterizes the development of choroidal neovascularization with associated subretinal fibrosis.
METHODS: The authors reviewed the records of five patients (6 eyes) with punctate inner choroidopathy who underwent submacular surgery for subfoveal choroidal neovascularization. Surgical specimens were examined using light and transmission electron microscopy.
RESULTS: Visual improvement was noted postoperatively in all six eyes, with follow-up ranging from 8 to 36 months (median, 14 months). Recurrences (6 in 4 eyes) were common. Five of the six recurrences required additional procedures: three were managed surgically, two with laser photocoagulation, and one with observation. "Bridging" of separate foci of choroidal neovascularization resulted in stellate or "dumbbell-shaped" areas of subretinal fibrosis in four of six eyes. Histopathologic evaluation of the excised tissue showed endothelial-lined vascular channels, retinal pigment epithelium, lymphocytes, plasma cells, fibrocytes, collagen fragments, and rarely, outer retinal elements.
CONCLUSIONS: Subfoveal choroidal neovascularization in punctate inner choroidopathy may be managed with submacular surgery. Recurrences are common and may result in substantial loss of vision. Choroidal neovascular membranes with an accompanying fibrotic reaction are responsible for the stellate or dumbbell-shaped areas of subretinal fibrosis. No beneficial effect was demonstrated using corticosteroid treatment of the choroidal neovascularization.

Entities:  

Mesh:

Year:  1996        PMID: 9003340     DOI: 10.1016/s0161-6420(96)30387-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  19 in total

1.  Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy.

Authors:  S Chatterjee; J M Gibson
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

2.  Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization.

Authors:  Paolo Lanzetta; Maurizio Battaglia Parodi; Massimo Ambesi-Impiombato; Giuseppe Ravalico; Francesco Bandello
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-22       Impact factor: 3.117

3.  Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation.

Authors:  A Hogan; U Behan; D J Kilmartin
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

4.  Early neovascular bridging of choroidal neovascularization after ranibizumab treatment.

Authors:  Juan Reche-Frutos; Cristina Calvo-Gonzalez; Juan Donate-Lopez; Julian Garcia-Feijoo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-21       Impact factor: 3.117

Review 5.  Inflammatory choroidal neovascular membrane in posterior uveitis-pathogenesis and treatment.

Authors:  Narendra Dhingra; Susan Kelly; Mohammed A Majid; Claire B Bailey; Andrew D Dick
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

6.  Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy.

Authors:  T Barth; F Zeman; H Helbig; M-A Gamulescu
Journal:  Int Ophthalmol       Date:  2017-04-19       Impact factor: 2.031

7.  A 39-year-old woman with unilateral metamorphosias.

Authors:  Lígia Ribeiro; Sidnei Barge; Luís Silva; Arnaldo Brandão; Dália Meira
Journal:  Digit J Ophthalmol       Date:  2011-11-20

8.  Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression.

Authors:  T Leslie; N Lois; D Christopoulou; J A Olson; J V Forrester
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

9.  [Punctate inner choroidopathy - Improvement in vision after anti-VEGF and photodynamic therapy. An 18-month follow-up control].

Authors:  S Weiss; R Winter; M W Meyer
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

10.  Pathological findings of multifocal choroiditis with panuveitis and punctate inner choroidopathy.

Authors:  Hiroyuki Shimada; Mitsuko Yuzawa; Tokihito Hirose; Hiroyuki Nakashizuka; Takayuki Hattori; Yoko Kazato
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.